Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
10-12 December, 2025
Saudi International Ex...Saudi International Expo
Not Confirmed
Not Confirmed
10-12 December, 2025
Antibody EngineeringAntibody Engineering
Not Confirmed
Not Confirmed
10-12 December, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
10-12 December, 2025
Saudi International Ex...Saudi International Expo
Industry Trade Show
Not Confirmed
10-12 December, 2025
Antibody EngineeringAntibody Engineering
Industry Trade Show
Not Confirmed
10-12 December, 2025
Digital content

16 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nordic-group-bv-through-its-subsidiary-nordic-pharma-inc-us-to-share-patient-data-and-patient-experience-study-for-lacrifill-canalicular-gel-a-novel-therapy-for-dry-eye-during-american-academy-of-ophthalmology-aao-20-302584748.html

24 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nordic-group-bv-through-its-subsidiary-nordic-pharma-inc-us-announces-launch-of-authorized-generic-of-maxitrol-neomycin-and-polymyxin-b-sulfates-and-dexamethasone-ophthalmic-suspension-302436485.html

23 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nordic-group-bv-through-its-subsidiary-nordic-pharma-inc-us-presenting-patient-data-and-patient-experience-study-for-lacrifill-canalicular-gel-a-novel-therapy-for-dry-eye-at-the-american-society-of-cataract-and-refract-302435031.html

28 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nordic-group-bv-through-its-subsidiary-nordic-pharma-inc-us-announces-details-of-lacrifill-canalicular-gel-poster-presentation-at-seco-2025-302388666.html

17 Oct 2024
// BUSINESSWIRE

12 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/alex-therapeutics-has-signed-an-exclusive-agreement-with-navamedic-for-the-development-of-a-companion-app-to-aid-in-the-treatment-of-parkinsons-disease-302246418.html
ABOUT THIS PAGE